Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
Status:
Withdrawn
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The investigators will test the hypothesis that aspirin or clopidogrel taken twice daily will
augment their antiplatelet efficacy in patients with an elevated platelet turnover (as
measured by the proportion of reticulated (young) platelets) compared with once daily dosing.